About Enhancer
| Enhancer ID: | E_00859 |
| Species: | Homo sapiens |
| Position : | chr6:33548076-33548616   |
| Year: | 2022 |
| Title: | A common deletion at BAK1 reduces enhancer activity and confers risk of intracranial germ cell tumors |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 35918310 |
| MONDO: | |
| Tissue: | Inner cell mass |
| Tissue Ontology ID: | UBERON:0000087 |
| Cell Source: | H1-hESC |
| CVCL ID: | |
| Cell Type: | embryonic stem cell |
| Cell Ontology ID: | CL:0002322 |
| Experiment Type: | Enhancer activity assay, TF binding assay |
| High Throughput Method: | ATAC-seq |
| Low Throughput Method: | Luciferase Reporter Assay |
About Target Gene
| Target gene : | BAK1 |
About TF
| TF name : |
About Regulatory State
| Regulatory State : | Silenced |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer Associated Network
Overlapping Enhancers (hg19)
1 found
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_00858 | chr6:33548076-33548616 | Embryonic Kidney | embryonic kidney cell | -- |
Expression of Target Genes for the Enhancer